General Information of Drug (ID: DMS3915)

Drug Name
AC 165198 Drug Info
Indication
Disease Entry ICD 11 Status REF
Diabetic complication 5A2Y Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMS3915

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
MLN1202 DM24SOL Metastatic cancer 2D50-2E2Z Phase 2 [3]
TTP889 DMCQARM Blood forming organ disorder JB64.1 Phase 2 [3]
AMG 876 DM1FJ9C Type-2 diabetes 5A11 Phase 1 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Measles virus Fusion glycoprotein (MeV F) TTUPB12 FUS_MEASC Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030890)
2 WO patent application no. 2013,1306,83, Xten conjugate compositions and methods of making same.
3 Emerging drugs for respiratory syncytial virus infection. Expert Opin Emerg Drugs. 2009 Jun;14(2):207-17.
4 Clinical pipeline report, company report or official report of Amgen.